Edit

About Us

Li Med one of the fastest growing Pharmaceutical Companies in India, was promoted by a group of young and experienced professionals and businessmen with the aim of providing International quality pharmaceutical products at very competitive and affordable pricing and also with the commitment to maintain highest standards and by adhering to the norms set by the Government of India. With the backing of strong brand management and a vision for scalability, Li Med Labs is poised to emerge as the Leader in the Indian pharma segment with the active support of its team of highly proficient industry professionals and also by partnering with established C&Fs and Stockists across India. We take pride in recording successful and consistent management of new product launches and exploring new territories across India..

Get in Touch

Contact Info

Rabiround

Short-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or ulcerative GERD; maintaining healing and reducing relapse rates of heartburn symptoms in patients with erosive or ulcerative GERD; treatment of daytime and nighttime heartburn and other symptoms associated with GERD; long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome; in combination with amoxicillin and clarithromycin to eradicate Helicobacter pylori in patients with H. pylori infection and duodenal ulcer disease.

Description

RABIROUND tablets contains Rabeprazole

Rabeprazole is a proton pump inhibitor.

Rabeprazole belongs to a group of antisecretory compounds that do not exhibit anticholinergic or H2receptor antagonist properties. They suppress gastric acid secretion by inhibiting gastric H+K+ ATPase at the secretory surface of the gastric parietal cells. Because this enzyme is regarded as an acid pump within the parietal cell, Rabeprazole has been characterized as a gastric proton pump inhibitor.

Rabeprazole blocks the final step of gastric acid secretion. In the gastric parietal cells, Rabeprazole is protonated, accumulated and is transformed to an active sulfonamide. When studied invitro, Rabeprazole is chemically activated at ph 1.2 with a half-life of 78 seconds. It inhibits acid transport in porcine gastric vesicles with a half-life of 90 seconds.

 

INDICATIONS

Duodenal ulcer
Healing and symptom relief of benign gastric ulcer.
GERD
Zollinger-Ellison syndrome.

 

CONTRAINDICATION

Hypersensitivity

 

SPECIAL PRECAUTION

Severe hepatic impairment and lactation.

 

DRUG INTERACTIONS

Elimination half –life of digoxin increases on administration of Rabeprazole.

 

ADVERSE EFFECTS

Headache, diarrhea, rash, infection and flu like symptoms

This should be administered strictly with the prescription and advise of medical practitioners only.

 

Related products

HOME
CONTACT
PRODUCTS
Facebook Twitter Linkedin

© Li Med Labs